Correction to Earlier Release From Jewish Hospital and University of Louisville
LOUISVILLE, Ky., July 24 /PRNewswire-USNewswire/ -- In today's announcement regarding the use of stem cells in the treatment of heart failure, we failed to make a critical distinction. Louisville researchers and physicians have performed the world's first phase-one FDA-approved clin...
First Skin Cancer Patients Treated With Electronic Brachytherapy (eBx) At University of Wisconsin Riverview Cancer Center
WISCONSIN RAPIDS, Wis., July 23 /PRNewswire/ -- Earlier this month the University
of Wisconsin Cancer Center Riverview became the first medical facility in the world to treat patients with a breakthrough treatment of skin cancer. Located within Riverview Hospital, Wisconsin Rapids, ...
Infant Formula Company Teams With the University of Virginia Pediatrics Department to Conduct Clinical Studies
GORDONSVILLE, Va., June 24 /PRNewswire/ -- PBM Products, LLC, a leading infant formula company that supplies store-brand infant formulas to Walmart, Sam's Club, Target, Kroger, CVS, Walgreens, and other retailers, has partnered with the University
of Virginia (U.Va.) to conduct clinical studies ...
Single Port Surgeries Now Performed at University Medical Center at Princeton
Advances Trend Toward Less-Invasive Approaches
PRINCETON, N.J., June 8 /PRNewswire/ -- Advancing the trend toward ever less invasive surgery, University
Medical Center at Princeton ( www.princetonhcs.org ) is now performing laparoscopic surgery by way of a single incision through the belly ...
Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient
ANN ARBOR, Mich., March 9 /PRNewswire/ -- Terumo Heart, Inc. today announced that NewYork-Presbyterian Hospital/ Columbia University
Medical Center recently became the second U.S. center, and first in the Northeast, to implant the DuraHeart(TM) Left-Ventricular Assist System as part of the DuraHe...
Cancer Therapy & Research Center at The University of Texas Health Science Center and Oncolytics Biotech(R) Inc. Announce Multi-Trial Clinical Research Collaboration
CALGARY, Feb. 4 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY ) and the Cancer Therapy & Research Center at The University
of Texas Health Science Center in San Antonio, (CTRC at UTHSCSA) announced a broad preclinical and clinical collaboration invol...
British Midlands University Announces Use of Gene Technology to Fight Lethal Hospital Acquired Infection University
of Nottingham Scientists Leading Major Study into Lethal 'Super' Strains of C.difficile
CHICAGO, Jan. 28 /PRNewswire/ -- The British Midlands Development Corporation today announced that scientists at The University
of Nottingham are leading a major European study to unravel the ...
WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System
UT Southwestern to Identify and Validate Novel Gene Expression Biomarkers Involved in Wound Healing with Innovative Gene Expression Platform
FREMONT, Calif., Jan. 8 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art gene exp...
InteRNA Technologies and VU University Medical Center to Develop microRNA-Based Diagnostics and Therapeutics for Cancer
BILTHOVEN and AMSTERDAM, The Netherlands, October 30 /PRNewswire/ --
InteRNA Technologies B.V. and VU university
medical center in Amsterdam,
VUmc, announce today the signing of a framework research agreement to
develop microRNA (miRNA)-based diagnostics and therapeutics for cancer
Gene Found Activated in 70% of Prostate Cancer Cases, George Washington University Medical Center Scientists Report
DRS. PATRICIA BERG AND ARNOLD SCHWARTZ LED TEAM, Article in Modern
Pathology set for print publication January 2009
BERG HAD ALSO DISCOVERED SAME GENE'S ACTIVATION IN MAJORITY OF BREAST
WASHINGTON, Oct. 24 /PRNewswire-USNewswire/ -- A gene has been found
activated in 70% of pr...
American College of Cardiology and Center of Excellence for Simulation Research of Western Michigan University (CESR) Partner for in situ Simulation to Improve Team Communication and Door-to-Balloon (D2B) Time
WASHINGTON, BATTLE CREEK, Mich., and EVANSTON, Ill., Oct. 20
/PRNewswire/ -- The American College of Cardiology (ACC) and the Center of
Excellence for Simulation Research (CESR) of Western Michigan University
announced the launch of an educational and research partnership, using in
Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay
The Study Will Compare the Results of Rosetta Genomics' microRNA-based
Test, miRview(TM) Squamous, Which Differentiates Squamous From non Squamous non Small Cell Lung Cancer, With Current Diagnostic Methods
A Test Based on the miRview(TM) Technology First Approved for Clinical use
Queen's University Chooses Xceed's Ziplex(R) System for Translational Research
Study to validate gene signature designed to predict outcomes in follicular lymphoma
WELLESLEY, Mass., Sept. 15 /PRNewswire/ -- Xceed Molecular, a pioneer
in the development of cost-effective, easy-to-use gene-expression analysis
systems, announced that Queen's Uni...
deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer
Detection may be used to complement and target screening for the disease;
findings will be integrated into the deCODEme(TM) personal genome scan.
REYKJAVIK, Iceland, Sept. 14 /PRNewswire-FirstCall/ -- Scientists at
deCODE genetics (Nasdaq: DCGN ) and colleagues at Radboud University
The University of Nottingham in the British Midlands Announces Breakthrough in Parkinson's Disease Research
Award Winning Research Team Makes Crucial Breakthrough in Battle to Prevent Onset of Parkinson's Disease
CHICAGO, Aug. 27 /PRNewswire/ -- The British Midlands Development
Corporation today announced that scientists at The University
have made a crucial breakthr...
Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services
BOSTON, Aug. 18 /PRNewswire-USNewswire/ -- Boston University
Milunsky, MB.B.Ch, D.Sc., President of the Center for Human Genetics, Inc.
("CHG") and Director of the Center for Human Genetics of Boston University,
announced that CHG will no longer offer testing services covered by pat...
First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan
National trial aims to help heart failure patients survive until
transplant, and may offer lower clot risk and less blood damage than
earlier heart devices
ANN ARBOR, Mich., Aug. 5 /PRNewswire-USNewswire/ -- Anthony Shannon
made history on July 30. That's when he became the first person in t...
Terumo Heart Obtains IRB Approval from the University of Michigan to Initiate DuraHeart(TM) Left Ventricular Assist System U.S. Pivotal Trial
ANN ARBOR, Mich., June 25 /PRNewswire/ -- Terumo Heart, Inc. announced
today approval from the Institutional Review Board (IRB) at the University
of Michigan to move forward with the DuraHeart(TM) Left Ventricular Assist
System (LVAS) U.S. Pivotal Trial for a Bridge-to-Transplant (BTT)
CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCyte's Glycoprotein Products in Heart Attack Disease Model
BOTHELL, Wash., June 3 /PRNewswire-FirstCall/ -- CellCyte Genetics
Corporation (CellCyte) (OTC Bulletin Board: CCYG) has selected the
Cardiovascular Phenotyping Core at Washington University
School of Medicine
in St. Louis to perform a study to further evaluate CellCyte's glycoprotein
Kiadis Pharma Announces Collaboration With the Julius Maximilians University of Wurzburg, Germany
Dr. Mielke Continues his Collaboration With Kiadis Pharma on ATIR(TM)
AMSTERDAM, May 29 /PRNewswire/ -- Biopharmaceutical company Kiadis
Pharma announces today the clinical development collaboration for its lead
product ATIR(TM) with Dr. Stephan Mielke and Professor Dr. Hermann Einsele
Infant Vaccines Produce Autism Symptoms in New Primate Study by University of Pittsburgh Scientists
Routine Safety Study That Government Scientists Refused To Do
Illustrates Vaccine Program And Mercury Health Risks Says SafeMinds
ATLANTA, May 19 /PRNewswire-USNewswire/ -- Findings released Friday
showed that infant monkeys given vaccines officially recommended by the CDC
and the American...
Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
NEW YORK, April 25 /PRNewswire-FirstCall/ -- Delcath Systems, Inc.
(Nasdaq: DCTH ) announced today that the Institutional Review Board (IRB) of
of Maryland Medical Center (UMMC) has approved UMMC's
participation in the Phase III study of the Company's Percutaneous Hepatic
Vermillion and the Ohio State University Report That Novel Diagnostic Test May Help Predict Risk for Relapse of TTP, A Serious Blood Disorder
- Findings Published in the British Journal of Hematology -
FREMONT, Calif., April 24 /PRNewswire-FirstCall/ -- Vermillion, Inc.
(Nasdaq: VRML ) today reported findings from an Ohio State University
clinical study that indicated that a surface-enhanced laser
Wayne State University and Oakwood Partner in New Device to Combat Congestive Heart Failure
DEARBORN, Mich., April 7, 2008 /PRNewswire-USNewswire/ -- Wayne State
University School of Medicine and Oakwood Healthcare System surgeons
successfully implanted a new device designed to combat congestive heart
failure in a 49-year-old patient. The device could become a leading tool in
Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
The Laboratory-Developed Test is Designed to Differentiate Squamous From
Non-Squamous Non-Small Cell Lung Cancer (NSCLC), Classifying Squamous Cell
Carcinoma of the Lung With Sensitivity of 96 Percent and Specificity of 90 Percent.
Accurate Diagnosis is Importa...
Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development
SAN DIEGO, April 3, 2008 /PRNewswire-FirstCall/ -- Vical Incorporated
(Nasdaq: VICL ) today announced that it has been awarded a two-year, $2.0
million Phase II Small Business Technology Transfer (STTR) grant from the
U.S. National Institute of Allergy and Infectious Diseases (NIAID) of the
UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
COLLEGE PARK, Md., Feb. 21 /PRNewswire-USNewswire/ -- The University
Maryland's Maryland Industrial Partnerships Program (MIPS) today announces
the approval of 18 new collaborative research projects between Maryland
companies and university
Worth $4.4 million, the new projects ...
Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway
Contracts Give Access to Diagnostic Application of Research Technologies
FULLERTON, Calif., Jan. 22 /PRNewswire-FirstCall/ -- Beckman Coulter,
Inc. (NYSE: BEC ) announced today that it has signed four agreements with
of Ireland, Galway (NUI Galway) to direct assay
Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
First Patients Enrolled and Being Treated
BETHESDA, Md., Dec. 27 /PRNewswire-FirstCall/ -- Northwest
Biotherapeutics, Inc. (OTC Bulletin Board: NWBO) (AIM: NWBT; NWBS) ("NWBT")
today announced that a Phase I/II clinical trial in at least 30 patients,
using DCVax(R)-L for recurre...
Raydiance Collaborates With Rutgers University and Nation's Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
Scientists Leveraging Precision and Power of Raydiance USP Laser Platform
to Separate Skin Layers Without Collateral Damage; Decontaminate Tissue; Speed Tissue Cleaning
Initial Proof of Concept Testing Successful During Feasibility Trials
PETALUMA, Calif. and NEW BR...
Tezampanel, TorreyPines Therapeutics' Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
Data Suggest Potential for Treating Motor System Disorders
LA JOLLA, Calif., Oct. 17 /PRNewswire/-- Tezampanel, a novel small
molecule currently in clinical development by TorreyPines Therapeutics,
Inc. (Nasdaq: TPTX ) for the treatment of acute migraine headache, was shown
in an indep...
Potential Breakthrough Cancer Treatment Emerges from MIPS-Funded Clinical Trial Teaming CSA Medical Inc. and University of Maryland Researchers
Results presented today at American College of Gastroenterology's
COLLEGE PARK, Md., Oct. 16 /PRNewswire-USNewswire/ -- A clinical trial
conducted by University
of Maryland School of Medicine researchers and CSA
Medical Inc. may yield a breakthrough treatment for pre-cancerous...
Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
Quark Expands Hearing Loss Program With Novel SiRNA Approaches To Noise- Induced Hearing Loss With Its First Drug Candidate, AHLI-11, For The
Prevention Of Chemotherapy-Induced Hearing Loss In Late Pre-IND Stage
FREMONT, Calif., Sept. 24 /PRNewswire/ -- Quark Pharmaceuticals, Inc.,
Boston University Biomedical Engineers Find Chink in Bacteria's Armor
Find Could Lead to More Effective Antibiotics Against 'Superbugs'
BOSTON, Sept. 6 /PRNewswire-USNewswire/ -- Biomedical researchers at
Boston University's College of Engineering may have discovered the path
toward developing better drugs capable of defeating so-called "superbugs,"
Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
Quark's First Hearing Loss Compound, AHLi-11, Slated for IND Filing By Year- End 2007
FREMONT, Calif., Aug. 20 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a
clinical-stage biopharmaceutical company focused on discovering and
developing novel RNA interference-based...
Beactica Announces Fragment-Based Drug Discovery Research Collaboration With GE Healthcare and Uppsala University
UPPSALA, Sweden, January 13 /PRNewswire/ -- Beactica AB, the Swedish
fragment-based drug discovery company, today announced a new research
collaboration agreement with GE Healthcare (Chalfont St. Giles, UK), the
world leading provider of molecular interaction analysis tools, and Uppsala
Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
ST. LOUIS, June 11 /PRNewswire/ -- Orion Genomics announced today that
the company entered into a worldwide exclusive license agreement with The
Johns Hopkins University
(JHU) to commercialize products that identify
patients at risk for colorectal cancer. The license is based on a suite of
BASF Officially Launches the Collaborative Advanced Research Initiative at Harvard University
- Opening celebrated with inaugural Symposium on Biofilms
CAMBRIDGE, Mass. and LUDWIGSHAFEN, Germany, April 29 /PRNewswire/ --
BASF today announced the official launch of the BASF Advanced Research
Initiative at Harvard University. The Advanced Research Initiative at
Nobel Laureate Dr. Gunter Blobel to Speak at Florida Atlantic University
BOCA RATON, Fla., Jan. 11 /PRNewswire-USNewswire/ -- Florida Atlantic
University and Scripps Florida will present the 2008 Distinguished Nobel
Laureate Lecture on Wednesday, January 16 from 4-5:30 p.m. in the
University Theatre, 777 Glades Road, Boca Raton. Gunter Blobel, M.D., Ph.D.
is the 19...
Alnylam and Stanford University Scientists Discover New Role for
microRNAs (miRNAs) in T Cell Biology and Immunity
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar 22, 2007 - Alnylam
Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics
company, announced today publication of a study in the journal Cell
by Alnylam and Stanford University
scientists on the role of miRNAs
in immunity. In the pre-clinical study,...